Familial ovarian cancer screening

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 20, Issue 2, 2006, Pages 321-338

  Rosenthal, Adam ^a   Jacobs, Ian ^a  

^a Napolitano and Prof David)   (United Kingdom)

Author keywords

CA125; Cancer; Familial; Ovarian; Screening; Ultrasound

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN;

BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL GENETICS; CLINICAL PRACTICE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC ACCURACY; FAMILIAL CANCER; FAMILY ATTITUDE; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; GYNECOLOGY; HIGH RISK POPULATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; OVARY CANCER; PATIENT SELECTION; PERITONEUM CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SALPINGOOOPHORECTOMY; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY; TREATMENT REFUSAL; UTERINE TUBE CARCINOMA;

ADULT; CA-125 ANTIGEN; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33644881920     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2005.10.017     Document Type: Review

References (52)

1. J.S. Barnholtz-Sloan A.G. Schwartz F. Qureshi et al. Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades American Journal of Obstetrics and Gynecology 189 2003 1120-1127
2. FIGO (International federation of gynecology and obstetrics) annual report on the results of treatment in gynecological cancer. International Journal of Gynaecology and Obstetrics; 2003; 83 Suppl 1: ix-xxii, 1-229.
3. Office of national statistics. Cancer Statistics Registrations Series MB1, HMSO, London. No. 32; 2001.
4. H.A. Risch J.R. McLaughlin D.E. Cole et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer American Journal of Human Genetics 68 2001 700-710
5. T.R. Rebbeck H.T. Lynch S.L. Neuhausen et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations The New England Journal of Medicine 346 2002 1616-1622
6. N.D. Kauff J.M. Satagopan M.E. Robson et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation The New England Journal of Medicine 346 2002 1609-1615
7. I. Jacobs D. Oram Screening for ovarian cancer Biomedicine and Pharmacotherapy 42 1988 589-596
8. E.J. Pavlik J.R. van Nagell Jr P.D. DePriest et al. Participation in transvaginal ovarian cancer screening: Compliance, correlation factors, and costs Gynecologic Oncology 57 1995 395-400
9. V. Beral P. Fraser C. Chilvers Does pregnancy protect against ovarian cancer? Lancet 1 1978 1083-1087
10. M. Schwartz C. Lerman M. Daly et al. Utilization of ovarian cancer screening by women at increased risk Cancer Epidemiology, Biomarkers and Prevention 4 1995 269-273
11. C.W. Drescher J. Nelson S. Peacock et al. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening Cancer Epidemiology, Biomarkers and Prevention 13 2004 600-606
12. I.J. Jacobs J. Mackay A.N. Rosenthal et al. Progress in the UK familial ovarian cancer screening study (UKFOCSS) Abstract Presented at 14th International Meeting of European Society of Gynaecological Oncology, Istanbul 2005
13. J.P. Struewing P. Hartge S. Wacholder et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews The New England Journal of Medicine 336 1997 1401-1408
14. E. Andolf E. Svalenius B. Astedt Ultrasonography for early detection of ovarian carcinoma British Journal of Obstetrics and Gynaecology 93 1986 1286-1289
15. I.J. Jacobs D.H. Oram Potential screening tests for ovarian cancer F. Sharp W.P. Mason R.E. Leake Ovarian Cancer 1990 Chapman and Hall Medical London 197-205
16. V.R. Zurawski Jr R.C. Knapp N. Einhorn et al. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma Gynecologic Oncology 30 1988 7-14
17. I.J. Jacobs S.J. Skates N. MacDonald et al. Screening for ovarian cancer: A pilot randomised controlled trial Lancet 353 1999 1207-1210
18. S.J. Skates U. Menon N. MacDonald et al. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women Journal of Clinical Oncology 21 10 supplement 2003 206-210
19. Menon U, Skates SJ, Lewis S, et al. A prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. Journal of Clinical Oncology; 2005; 23: 7919-26.
20. S. Campbell V. Bhan P. Royston et al. Transabdominal ultrasound screening for ovarian cancer British Medical Journal 299 1989 1363-1367
21. P.D. DePriest D. Shenson A. Fried et al. A morphology index based on sonographic findings in ovarian cancer Gynecologic Oncology 51 1993 7-11
22. S.C. Modesitt E.J. Pavlik F.R. Ueland et al. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter Obstetrics and Gynaecology 102 2003 594-599
23. A. Kurjak H. Schulman A. Sosic et al. Transvaginal ultrasound, color flow, and Doppler waveform of the postmenopausal adnexal mass Obstetrics and Gynaecology 80 1992 917-921
24. A. Antoniou P.D.P. Pharoah S. Narod et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies American Journal of Human Genetics 72 2003 1117-1130
25. A. Liede B.Y. Karlan R.L. Baldwin et al. Cancer incidence in a population of jewish women at risk of ovarian cancer Journal of Clinical Oncology 20 2002 1570-1577
26. R. Hogg M. Friedlander Biology of epithelial ovarian cancer: implications for screening women at high genetic risk Journal of Clinical Oncology 22 2004 1315-1327
27. K. Tiller B. Meiser P. Butow et al. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: A prospective study Gynecologic Oncology 86 2002 212-219
28. Jacobs IJ. Screening for familial ovarian cancer: The need for well designed prospective studies. Journal of Clinical Oncology; 2005; 23: 5443-5445.
29. P.C. Prorok G.L. Andriole R.S. Bresalier et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial Controlled Clinical Trials 21 6 supplement 2000 273S-309S
30. Z. Weiner D. Beck M. Shteiner et al. Screening for ovarian cancer in women with breast cancer with transvaginal sonography and color flow imaging Journal of Ultrasound in Medicine 12 1993 387-393
31. M.G. Muto D.W. Cramer D.L. Brown et al. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center Gynecologic Oncology 51 1993 12-20
32. J.L. Belinson C. Okin G. Casey et al. The familial ovarian cancer registry: Progress report Cleveland Clinic Journal of Medicine 62 1995 129-134
33. J. Menkiszak A. Jakubowska J. Gronwald et al. Hereditary ovarian cancer: Summary of 5 years of experience Ginekologia Polska 69 1998 283-287
34. B.Y. Karlan L.J. Raffel G. Crvenkovic et al. A multidisciplinary approach to the early detection of ovarian carcinoma: Rationale, protocol design, and early results American Journal of Obstetrics and Gynecology 169 1993 494-501
35. B.Y. Karlan R.L. Baldwin E. Lopez-Luevanos et al. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening American Journal of Obstetrics and Gynecology 180 1999 917
36. A. Dorum G.B. Kristensen V.M. Abeler et al. Early detection of familial ovarian cancer European Journal of Cancer 32A 1996 1645-1651
37. A. Dorum K. Heimdal K. Lovslett et al. Prospectively detected cancer in familial breast/ovarian cancer screening Acta Obstetricia et Gynecologica Scandinavica 78 1999 906-911
38. J.R. Van Nagell Jr P.D. DePriest M.B. Reedy et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer Gynecologic Oncology 77 2000 350-356
39. K.J. Taylor P.E. Schwartz Cancer screening in a high risk population: A clinical trial Ultrasound in Medicine and Biology 27 2001 461-466
40. L. Scheuer N. Kauff M. Robson et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers Journal of Clinical Oncology 20 2002 1260-1268
41. S. Laframboise R. Nedelcu J. Murphy et al. Use of CA-125 and ultrasound in high-risk women International Journal of Gynecological Cancer 12 2002 86-91
42. A. Tailor T.H. Bourne S. Campbell et al. Results from an ultrasound-based familial ovarian cancer screening clinic: A 10-year observational study Ultrasound in Obstetrics and Gynecology 21 2003 378-385
43. M.H. Fries B.J. Hailey J. Flanagan D. Licklider Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ ovarian cancer: Report of a phase II trial Military Medicine 169 2004 411-416
44. Stirling D, Evans DG, Pichert G, et al. Screening for familial ovarian cancer: Failure of current protocols to detect ovarian cancer at an early FIGO stage. Journal of Clinical Oncology; 2005.
45. U. Menon I.J. Jacobs Tumour markers and screening J.S. Berek N.F. Hacker Practical Gynaecologic Oncology 4th edn 2005 Philadelphia Lippincott, Williams and Wilkins 43-66
46. G. Mor I. Visintin Y. Lai et al. Serum protein markers for early detection of ovarian cancer Proceedings of the National Academy of Sciences 102 2005 7677-7682
47. E.F. Petricoin A.M. Ardekani B.A. Hitt et al. Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 2002 572-577
48. J.M. Sorace M. Zhan A data review and re-assessment of ovarian cancer serum proteomic profiling BMC Bioinformatics 4 2003 24
49. Z. Zhang R.C. Bast Jr Y. Yu et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Research 64 2004 5882-5890
50. B. Ye D.W. Cramer S.J. Skates et al. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry Clinical Cancer Research 9 2003 2904-2911
51. S.A. Gayther J. Mangion P. Russell et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene Nature Genetics 15 1997 103-105
52. S.A. Narod H. Risch R. Moslehi et al. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary ovarian cancer clinical study group The New England Journal of Medicine 339 1998 424-428